Royal Numico/Rexall
This article was originally published in The Tan Sheet
Executive Summary
Firms settle class action litigation with shareholders seeking to enjoin Rexall directors from proceeding with the merger (1"The Tan Sheet" May 8, pp. 3-4). The agreement calls for the firms to lower the maximum fee and expenses reimbursement payable by Rexall to Royal Numico in the event the merger falls through to $60 mil. from $79 mil., provide Rexall shareholders with appraisal rights related to the merger and confirm to stockholders the absence of any inquiries by third parties concerning possibly buying Rexall. Numico and Rexall have denied wrongdoing in the case, saying they entered into the settlement to avoid the expense and distraction of continued litigation
You may also be interested in...
Royal Numico/Rexall Sundown Eyes Private Label As Key Growth Area
Combined Royal Numico/Rexall Sundown operations regard their potential for private label sales in the U.S. mass market to be "very high," the firms reported during a May 1 teleconference. Numico and Rexall have little presence in U.S. private label now but appear to be pondering it for the future despite the traditional low margins of the products.
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands